Key result
Updated AHA/ACCF guidelines outline secondary prevention and risk-reduction therapies for atherosclerotic vascular disease.
This document provides the 2011 update to the AHA/ACCF guidelines for secondary prevention and risk reduction therapy in patients with coronary and other atherosclerotic vascular disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2011) studied this question. The 2011 AHA/ACCF update provides revised clinical guidelines for secondary prevention and risk reduction therapy in patients with coronary and other atherosclerotic vascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: